Stay updated on Pembrolizumab & Romidepsin Combo Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Romidepsin Combo Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a Locations section with a Texas site (M.D. Anderson Cancer Center) and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the combined 'Texas Locations' label (v3.3.2).
    Difference
    0.2%
    Check dated 2025-12-23T21:28:57.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:53:03.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Removed the government funding operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:15:30.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page shows the same study details with minor formatting adjustments and an updated last-updated timestamp, and no substantive changes to the study design or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:20:46.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    - Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T06:37:57.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    - Capitalization normalization: 'Angioimmunoblastic t-cell lymphoma' (lowercase t) merged into the more proper 'Angioimmunoblastic T-cell lymphoma'. - Version update: revision moved from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T03:12:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Romidepsin Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Romidepsin Combo Clinical Trial page.